Holdings

Regeneron Pharmaceuticals, Inc.

As of Sep 30, 2026, Regeneron Pharmaceuticals, Inc. reported 3 positions worth US$180M. Largest: Parabilis Medicines, Inc., Intellia Therapeutics, Inc. and Adicet Bio, Inc. What it bought and sold, with each filing.

CompanySharesValue as reportedChangeAs of
Parabilis Medicines, Inc.4.17MUS$135Mno changeSep 30, 2026
Intellia Therapeutics, Inc.3.7MUS$44.7Mno changeSep 30, 2026
Adicet Bio, Inc.60,511US$432Kno changeSep 30, 2026